Clinical Trial Update: Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating CS-3150 in hypertensive patients with type 2 diabetes and albuminuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• CS-3150 (CS-3150)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Hypertension | Phase 3 | Status: COMPLETED